Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07016698 · ClinicalTrials.gov registry record · NA
Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)
A NA study of Peripheral Arterial Disease(PAD), sponsored by C. R. Bard.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 2
- Study locations
NCT07016698 is a NA study of Peripheral Arterial Disease(PAD) that is actively recruiting participants, run by C. R. Bard. The registered enrollment target is 600 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT07016698, a NA study of Peripheral Arterial Disease(PAD), is actively recruiting participants, sponsored by C. R. Bard.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 2
- Study locations
Study Summary
The XTRACT Registry is a prospective, single arm multicenter study on the use of on the Rotarex(TM) Rotational Excisional Atherectomy System.
Conditions Studied
Interventions
- DEVICE Rotarex(TM) Rotational Excisional Atherectomy System
Study Locations (2)
Florida
- Radiology and Imaging Specialists - Lakeland
Texas
- Vital Heart and Vein - Humble
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2025-09-29 |
| Est. Completion | 2029-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07016698
The ClinicalTrials.gov registry entry for NCT07016698 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Arterial Disease(PAD) appearing as the primary indexed condition, and to 1 intervention - of which Rotarex(TM) Rotational Excisional Atherectomy System is the first listed.
NCT07016698 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Texas.
Frequently Asked Questions
What is clinical trial NCT07016698 about?
NCT07016698 is a clinical study titled "Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)". The XTRACT Registry is a prospective, single arm multicenter study on the use of on the Rotarex(TM) Rotational Excisional Atherectomy System.
What is the current status of trial NCT07016698?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2025-09-29. Estimated completion is 2029-05-31.
What conditions does trial NCT07016698 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease(PAD).
What interventions are being tested in trial NCT07016698?
The interventions under investigation include: Rotarex(TM) Rotational Excisional Atherectomy System (DEVICE).
Who is sponsoring clinical trial NCT07016698?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07016698 being conducted?
This trial has 2 study locations across Florida, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.